Your browser doesn't support javascript.
loading
The effectiveness of an emotion-focused educational programme in reducing diabetes distress in adults with type 2 diabetes mellitus at 12-month follow-up: a cluster randomized controlled trial.
Chew, Boon-How; Vos, Rimke C; Fernandez, Aaron; Shariff Ghazali, Sazlina; Shamsuddin, Nurainul Hana; Ismail, Mastura; Rutten, Guy E H M.
Affiliation
  • Chew BH; Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Vos RC; Department of Public Health and Primary Care/ LUMC Campus The Hague, Leiden University Medical Center, The Netherlands.
  • Fernandez A; Department of Psychiatry, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Shariff Ghazali S; Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Shamsuddin NH; Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
  • Ismail M; Health Clinic Seremban 2, Negeri Sembilan, Malaysia.
  • Rutten GEHM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.
Ther Adv Endocrinol Metab ; 10: 2042018819853761, 2019.
Article in En | MEDLINE | ID: mdl-31210922
ABSTRACT

BACKGROUND:

Diabetes distress (DD) is an increasingly important part of clinical medicine, diabetes self-management and research topic in people with diabetes mellitus. The present study evaluated the effectiveness of a value-based emotion-focused educational program in Malay adults with type 2 diabetes (VEMOFIT) at 12-month follow-up compared with a program with systematic attention to participants' emotions (attention-control).

METHODS:

VEMOFIT consisted of four biweekly group sessions and a booster session after 3 months; the attention-control program consisted of three sessions over the same period. Intention-to-treat analysis with multilevel mixed modelling was done to estimate the intervention effect.

RESULTS:

Participants (n = 124) randomized to VEMOFIT (n = 53) or attention-control (n = 71). Mean (SD) age 55.7 (9.7) years, median diabetes duration 7.0 (8.0) years and mean HbA1c level 9.7% (82 mmol/mol). The mean DD (DDS-17 scale) level decreased in both groups (from 3.4 to 3.3 versus 3.1-2.5, respectively), significantly more in the attention-control group [adjusted difference -0.6, 95% confidence interval (CI) -1.1, -0.2]. The VEMOFIT group had a significant improvement in self-efficacy (DMSES, range 0-200; adjusted difference 16.4, 99.4% CI 1.9, 30.9). Other outcomes did not differ.

CONCLUSIONS:

Because the attention-control program resulted in a decreased DD 1 year later, its implementation on a larger scale seems justified. TRIAL REGISTRATION NCT02730078; NMRR-15-1144-24803.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Ther Adv Endocrinol Metab Year: 2019 Document type: Article Affiliation country: Malaysia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Ther Adv Endocrinol Metab Year: 2019 Document type: Article Affiliation country: Malaysia